Alcyone Therapeutics Inc. logo — Alcyone is pioneering next-generation intra-CSF (cerebrospin...

Alcyone Therapeutics Inc.

Alcyone is pioneering next-generation intra-CSF (cerebrospinal fluid) CNS precision gene-based therapies

Founded 2010 United States Lowell, United States 37 employees Series Unknown Total: $23.00M Biotechnology, Health and Wellness

General Information

Company Name Alcyone Therapeutics Inc.
Founded Year 2010
Location United States Lowell, United States +1
Employees 37
Industries Biotechnology, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when Alcyone Therapeutics Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Alcyone Therapeutics Inc.

Alcyone Therapeutics Inc. is a pioneering company in the biotechnology and health and wellness industries, focusing on next-generation intra-CSF (cerebrospinal fluid) CNS precision gene-based therapies. Established in 2010, the company's mission is to develop therapeutic and precision delivery solutions to bring impactful change to people living with neurological conditions and their support network.

The most recent investment in Alcyone Therapeutics Inc. was a $23.00M Venture Round funded on 09 June 2021. The investment was led by RTW Investments.

Alcyone Therapeutics Inc. is at the forefront of advancing treatment options for neurological conditions through innovative gene-based therapies, and the recent investment underscores investor confidence in the company's vision and potential impact on the healthcare industry.

Taxonomy: Precision Medicine, Gene Therapy, Neurological Conditions, CNS Therapies, Therapeutic Solutions, Precision Delivery, Genetic Therapies, Neuroscience, Intra-CSF Therapies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
09 Jun 2021

Alcyone Therapeutics Inc. Alternatives & Competitors

Alcyone Therapeutics Inc. vs

Innovating the future of precision antibiotics with naturally occurring bacteriocin therapies.

Seed
2-10 employees
Biotechnology
Alcyone Therapeutics Inc. vs
ENDPOINT HEALTH
ENDPOINT HEALTH United States

Precision immunology therapies

Series A
7 employees
Health Care
Alcyone Therapeutics Inc. vs
Leucid Bio
Leucid Bio United Kingdom

Thinking laterally about CAR-T. Develops Autologous and Allogeneic cell and gene Therapies for hard...

Series A
23 employees
Biotechnology, Health Care

FAQ About Alcyone Therapeutics Inc.

Alcyone is pioneering next-generation intra-CSF (cerebrospinal fluid) CNS precision gene-based therapies
Alcyone Therapeutics Inc. was founded in 2010.
Alcyone Therapeutics Inc. is headquartered in Lowell, United States.
Alcyone Therapeutics Inc. operates in the following industries: Biotechnology, Health and Wellness.
Alcyone Therapeutics Inc. has approximately 37 employees.
Alcyone Therapeutics Inc. has completed 1 funding round, raising a total of $23.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Alcyone Therapeutics Inc. include Glox Therapeutics, ENDPOINT HEALTH, Leucid Bio, CIS Pharma, Fore Biotherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alcyone Therapeutics Inc. and Glox Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Alcyone Therapeutics Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes